The Taiwan Food and Drug Administration (TFDA) on Saturday asked the public to refrain from procuring GLP-1 and GIP weight-loss medications from unknown sources, after the United Kingdom issued a heightened warning about the drugs last week.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar up sharply in Taipei trading
10/16/2026 10:22 AM - Society
Taiwan headline news
10/16/2026 10:19 AM - Business
Taiwan shares open higher
10/16/2026 09:11 AM - Politics
Cabinet approves upgraded dementia care plan targeting '888' goals by 2035
10/15/2026 09:03 PM - Politics
Taipei mayoral candidates Chiang, Shen to debate Oct. 31
10/15/2026 08:56 PM